{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:31:30Z","timestamp":1793763090925,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["XHZD202411"],"award-info":[{"award-number":["XHZD202411"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["GFXK202501"],"award-info":[{"award-number":["GFXK202501"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tice.2026.103584","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:33:44Z","timestamp":1778243624000},"page":"103584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ablation of ASF1B mitigates the proliferation of A549 cells and enhances anti-PD-L1 therapy by regulating ferroptosis"],"prefix":"10.1016","volume":"102","author":[{"given":"Jiamin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tice.2026.103584_bib1","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/molbev\/mst086","article-title":"Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b","volume":"30","author":"Abascal","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.tice.2026.103584_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1148389","article-title":"The role of p53 in anti-tumor immunity and response to immunotherapy","volume":"10","author":"Carlsen","year":"2023","journal-title":"Front Mol. Biosci."},{"issue":"10","key":"10.1016\/j.tice.2026.103584_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"10.1016\/j.tice.2026.103584_bib4","first-page":"249","article-title":"Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers","volume":"18","author":"Chen","year":"2023","journal-title":"Prz. Gastroenterol."},{"issue":"2","key":"10.1016\/j.tice.2026.103584_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/pme-2020-0112","article-title":"Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma","volume":"18","author":"Feng","year":"2021","journal-title":"Per Med"},{"key":"10.1016\/j.tice.2026.103584_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110083","article-title":"p53-Dependent ferroptosis pathways in sepsis","volume":"118","author":"Gao","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.tice.2026.103584_bib7","article-title":"SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00408-025-00801-x","article-title":"Update 2025: Management of Non\u2011Small-Cell Lung Cancer","volume":"203","author":"Jeon","year":"2025","journal-title":"Lung"},{"key":"10.1016\/j.tice.2026.103584_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102289","article-title":"Anlotinib induced ferroptosis through the p53\/xCT\/GPX4 pathway in non-small cell lung cancer","volume":"53","author":"Jiang","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.tice.2026.103584_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3233\/CBM-210490","article-title":"Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer","volume":"34","author":"Kim","year":"2022","journal-title":"Cancer Biomark."},{"issue":"8","key":"10.1016\/j.tice.2026.103584_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"12","key":"10.1016\/j.tice.2026.103584_bib13","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.ymthe.2024.09.026","article-title":"PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders","volume":"32","author":"Lee","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","article-title":"N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer","volume":"20","author":"Liu","year":"2021","journal-title":"Mol. Cancer"},{"issue":"W1","key":"10.1016\/j.tice.2026.103584_bib15","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gkab418","article-title":"GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA","volume":"49","author":"Li","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2020.10.021","article-title":"NAD(+) Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion","volume":"33","author":"Lv","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib17","article-title":"KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K\/AKT signaling pathway","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib18","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/s41467-021-22875-w","article-title":"Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS\/p53 mutant lung cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2026.103584_bib19","article-title":"ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib20","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.tice.2026.103584_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"7755","key":"10.1016\/j.tice.2026.103584_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tice.2026.103584_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4149\/neo_2021_210818N1181","article-title":"ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway","volume":"69","author":"Wang","year":"2022","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.tice.2026.103584_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41420-020-00355-2","article-title":"Ferroptosis: a new approach for immunotherapy","volume":"6","author":"Zeng","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tice.2026.103584_bib25","article-title":"ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.tice.2026.103584_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102477","article-title":"ASF1B is an essential prognostic indicator linked to the growth and resistance characteristics of bladder cancer","volume":"89","author":"Zhang","year":"2024","journal-title":"Tissue Cell"},{"key":"10.1016\/j.tice.2026.103584_bib27","article-title":"ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.tice.2026.103584_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626663","article-title":"Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma","volume":"11","author":"Zhan","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.tice.2026.103584_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216796","article-title":"Activation of the FOXM1\/ASF1B\/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer","volume":"589","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"issue":"48","key":"10.1016\/j.tice.2026.103584_bib30","article-title":"ASF1B acted as a prognostic biomarker for stomach adenocarcinoma","volume":"102","author":"Zhao","year":"2023","journal-title":"Med. (Baltim. )"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:18:09Z","timestamp":1784067489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S0040816626002776"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103584","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of ASF1B mitigates the proliferation of A549 cells and enhances anti-PD-L1 therapy by regulating ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103584"}}